These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6197639)

  • 21. Naloxone may be beneficial in the treatment of tardive dyskinesia.
    Blum I; Munitz H; Shalev A; Roberts E
    Clin Neuropharmacol; 1984; 7(3):265-7. PubMed ID: 6386154
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of centrally administered neuropeptides on the development of stress-induced gastric ulcers in rats.
    Hernandez DE; Nemeroff CB; Orlando RC; Prange AJ
    J Neurosci Res; 1983; 9(2):145-57. PubMed ID: 6302295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiologic basis of tardive dyskinesia.
    Baldessarini RJ; Tarsy D
    Adv Biochem Psychopharmacol; 1980; 24():451-5. PubMed ID: 6105793
    [No Abstract]   [Full Text] [Related]  

  • 24. Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia.
    Baldessarini RJ; Tarsy D
    Int Rev Neurobiol; 1979; 21():1-45. PubMed ID: 43842
    [No Abstract]   [Full Text] [Related]  

  • 25. Naloxone and tardive dyskinesia.
    Sandyk R; Snider SR
    Biol Psychiatry; 1985 Dec; 20(12):1335-6. PubMed ID: 4063426
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuropeptides and pain.
    Carr DB; Lipkowski AW
    Agressologie; 1990 Apr; 31(4):173-7. PubMed ID: 1701617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain peptides as neurotransmitters.
    Snyder SH
    Science; 1980 Aug; 209(4460):976-83. PubMed ID: 6157191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinergic treatments for tardive dyskinesia.
    Alphs LD; Davis JM
    Mod Probl Pharmacopsychiatry; 1983; 21():168-86. PubMed ID: 6140629
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuropeptides as regulators of consummatory behaviors.
    Levine AS; Morley JE; Gosnell BA; Billington CJ; Krahn DD
    J Nutr; 1986 Nov; 116(11):2067-77. PubMed ID: 2878983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphine in tardive and idiopathic dystonia (short communication).
    Berg D; Becker G; Naumann M; Reiners K
    J Neural Transm (Vienna); 2001; 108(8-9):1035-41. PubMed ID: 11716139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia.
    Tsai G; Goff DC; Chang RW; Flood J; Baer L; Coyle JT
    Am J Psychiatry; 1998 Sep; 155(9):1207-13. PubMed ID: 9734544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neuropeptides.
    Sweet WH
    Neurosurgery; 1977; 1(3):311-6. PubMed ID: 28494
    [No Abstract]   [Full Text] [Related]  

  • 33. [Tardive dyskinesia].
    Säkö E; Marttila R; Rinne UK
    Duodecim; 1982; 98(13):1008-15. PubMed ID: 6127202
    [No Abstract]   [Full Text] [Related]  

  • 34. The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia.
    Stoessl AJ; Polanski E; Frydryszak H
    Mov Disord; 1993 Oct; 8(4):445-52. PubMed ID: 7901759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of des-tyrosine-gamma-endorphin in tardive dyskinesia.
    Casey DE; Korsgaard S; Gerlach J; Jørgensen A; Simmelsgaard H
    Arch Gen Psychiatry; 1981 Feb; 38(2):158-60. PubMed ID: 7011248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyphosphoinositide metabolism in rat brain: effects of neuropeptides, neurotransmitters and cyclic nucleotides.
    Jolles J; van Dongen CJ; ten Haaf J; Gispen WH
    Peptides; 1982; 3(5):709-14. PubMed ID: 6129617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptides with a dual function: central neuroregulators and gut hormones.
    Loonen JM; Soudijn W
    J Physiol (Paris); 1979; 75(8):831-50. PubMed ID: 95416
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of cholecystokinin-like immunoreactivity in the nervous system. Co-existence with classical neurotransmitters and other neuropeptides.
    Hökfelt T; Skirboll L; Everitt B; Meister B; Brownstein M; Jacobs T; Faden A; Kuga S; Goldstein M; Markstein R
    Ann N Y Acad Sci; 1985; 448():255-74. PubMed ID: 2411182
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurotransmitters and CNS disease. Schizophrenia.
    Snyder SH
    Lancet; 1982 Oct; 2(8305):970-4. PubMed ID: 6127468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.